Different Impact Of Antiretroviral Drugs On Bone Differentiation In An In Vitro Model.

Item

http://www.wikidata.org/entity/Q38895284

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Different Impact Of Antiretroviral Drugs On Bone Differentiation In An In Vitro Model.

@en

type

Item

label

Different Impact Of Antiretroviral Drugs On Bone Differentiation In An In Vitro Model.

@en

prefLabel

Different Impact Of Antiretroviral Drugs On Bone Differentiation In An In Vitro Model.

@en

P1476

Different Impact Of Antiretroviral Drugs On Bone Differentiation In An In Vitro Model.

@en

P2093

Angela Lucariello

http://www.w3.org/2001/XMLSchema#string

Antonio Chirianni

http://www.w3.org/2001/XMLSchema#string

Antonio De Luca

http://www.w3.org/2001/XMLSchema#string

Germano Guerra

http://www.w3.org/2001/XMLSchema#string

Maria Aurora Carleo

http://www.w3.org/2001/XMLSchema#string

Rosaria Viglietti

http://www.w3.org/2001/XMLSchema#string

Vincenzo Esposito

http://www.w3.org/2001/XMLSchema#string

Vincenzo Sangiovanni

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine

Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial

Tenofovir treatment of primary osteoblasts alters gene expression profiles: implications for bone mineral density loss

Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.

Effects of vitamin D supplementation on the bone specific biomarkers in HIV infected individuals under treatment with efavirenz

Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms.

Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy o

Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection

Prevalence and risk factors of low bone mineral density in Korean HIV-infected patients: impact of abacavir and zidovudine

P304

2188-2194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.25169

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Nicola Coppola

Angelica Perna

P577

2015-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25808410

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug